Ozempic has delivered impressive results for millions of Americans, but not everyone can stomach the cost of popular weight loss drugs.
Depending on a patient’s location, insurance coverage and dosage, a monthly supply of semaglutide can cost up to $1200 a month. And, for many people, the steep price tag isn’t the only barrier.
GLP-1 medications like Ozempic and Wegovy typically require a doctor’s evaluation and a prescription, as well as frequent pick-ups from the pharmacy. It’s a process that can be time-consuming and expensive. But, with the right program, it doesn’t have to be.
MyStart is one of the leading telehealth platforms aiming to transform how weight-loss medications are prescribed, with an ambitious goal of making the process faster and more affordable.
Getting started is simple. New users begin with a short health intake quiz, providing some basic information on their health and goals. Depending on the individual’s needs, follow-up bloodwork and video consultations may be required.
In many cases, MyStart can approve a prescription within 24 hours, with medication arriving at the patient’s front door in as little as 48 hours.
The program starts at $299/month, but the cost covers more than injections. Patients receive access to U.S. board-certified clinicians nationwide, expedited FedEx shipping, personalized dosage adjustments and ongoing support from a dedicated patient care coordination team.
“We’re passing our efficiencies back to our patients,” MyStart CEO Matthew Stern explained. “The more we scale, the more affordable this becomes. Our goal is long-term health, not just short-term results.”
Affordability isn’t just about competitive pricing; it’s about cost transparency and consistency. At MyStart, the initial price for medication and ongoing care will never increase from a user’s original plan, even if their dosage changes over time.
The company’s Chief Medical Officer, Dr. Ritu Chopra, has also highlighted that MyStart is there to support patients every step of the way, not just when they need a prescription.
“We built MyStart to take the confusion out of GLP-1 care,” says Dr. Ritu Chopra, Chief Medical Officer. “We’ve designed a complete protocol, not just a prescription, and we’re proud to offer under-24-hour turnaround on consultations and 48-hour delivery.”
Unlike some traditional providers, they offer a structured 90-day program that includes comprehensive medical oversight. Users can connect with MyStart clinicians as often as needed to discuss side effects, track progress, or adjust dosage.
On average, users lose 22 pounds within their first six months with MyStart. Aside from supporting their weight loss goals, many reviewers have credited the program for bringing back their confidence and “changing their lives.”
“I had tried every diet out there and was about to give up,” one pleased reviewer said. “MyStart helped me get on GLP-1, and just four months later, I’m in love with my new body!”
Even with its revolutionary impact in the weight-loss space, this is just the beginning for MyStart. The company has also expanded its services to include women’s hormone health, metabolic longevity, and personalized wellness, providing patients’ a full spectrum of care to take charge of their health.
MyStart is redefining what modern care looks like in a space where access to effective weight-loss treatments is often blocked by high costs and complex processes. No long waits, inflated prices or unanswered questions — just real, accessible care from anywhere.
Why Trust Post Wanted by the New York Post